Global Premature Ejaculation Treatment Market 2016-2020

2016-08-05
Price :
Published : Aug-2016
No. of Pages : 57

Premature ejaculation refers to the discharge of semen shortly before or after penetration during sexual intercourse, thereby leading to an unsatisfactory sex life and affecting the patient’s relationship with their partner. There is no proper cause that can be associated with the condition. However, personal distress and anxiety are possible attributes.

The analyst forecast global premature ejaculation treatment market to grow at a CAGR of 9.65% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the global premature ejaculation treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of premature ejaculation drugs and premature ejaculation solutions.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report Global Premature Ejaculation Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Absorption Pharmaceuticals
  • Allergan
  • Innovus Pharmaceuticals
  • Plethora

Other prominent vendors

  • Aytu BioScience
  • Bayer
  • Dong-A Pharmaceutical
  • Eli Lilly
  • Emcure
  • Futura Medical
  • GlaxoSmithKline
  • NeuroHealing Pharmaceuticals
  • Pfizer

Market driver

  • Rise in number of erectile dysfunction cases
  • For a full, detailed list, view our report

Market challenge

  • Threat of alternative treatments
  • For a full, detailed list, view our report

Market trend

  • Increase in awareness of premature ejaculation
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Top Trends in Healthcare and OTC 2017: Exploring OTC medication, vitamins, minerals and supplements; functional food and drink; and sports nutrition categories

Top Trends in Healthcare and OTC 2017: Exploring OTC medication, vitamins, minerals and supplements; functional food and drink; and sports nutrition categories Summary Global consumers are becoming more health-conscious as a reaction to rising obesity levels and lifestyle-related illnesses, such as diabetes, in the modern world. Consumers' busy lives are a major driver for the healthcare and OTC market as people opt for more convenient, multifunctional, and personalized products that better target their specific needs. Over-the-counter (OTC) drugs are those sold directly to a consumer without a prescription from a healthcare professional, as compared to prescription drugs, which may be sold only to consumers possessing a valid prescription. The pressures of modern life are taking their......
$3450

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for March 2017 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in March 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides ......
$1000

Arterial Thrombosis Global Clinical Trials Review, H1, 2017

Arterial Thrombosis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arterial Thrombosis Global Clinical Trials Review, H1, 2017" provides an overview of Arterial Thrombosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Thrombosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical t......
$2500

Arteriosclerosis Global Clinical Trials Review, H1, 2017

Arteriosclerosis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arteriosclerosis Global Clinical Trials Review, H1, 2017" provides an overview of Arteriosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriosclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials databa......
$2500

Arteriovenous Fistula Global Clinical Trials Review, H1, 2017

Arteriovenous Fistula Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arteriovenous Fistula Global Clinical Trials Review, H1, 2017" provides an overview of Arteriovenous Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriovenous Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Cl......
$2500

Artery Stenosis Global Clinical Trials Review, H1, 2017

Artery Stenosis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Artery Stenosis Global Clinical Trials Review, H1, 2017" provides an overview of Artery Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Artery Stenosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Arthralgia Global Clinical Trials Review, H1, 2017

Arthralgia Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Arthralgia Global Clinical Trials Review, H1, 2017" provides an overview of Arthralgia clinical trials scenario. This report provides top line data relating to the clinical trials on Arthralgia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are ......
$2500

Articular Cartilage Defect Global Clinical Trials Review, H1, 2017

Articular Cartilage Defect Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Articular Cartilage Defect Global Clinical Trials Review, H1, 2017" provides an overview of Articular Cartilage Defect clinical trials scenario. This report provides top line data relating to the clinical trials on Articular Cartilage Defect. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

Ascites Global Clinical Trials Review, H1, 2017

Ascites Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Ascites Global Clinical Trials Review, H1, 2017" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated fro......
$2500

Asperger Syndrome Global Clinical Trials Review, H1, 2017

Asperger Syndrome Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Asperger Syndrome Global Clinical Trials Review, H1, 2017" provides an overview of Asperger Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Asperger Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials da......
$2500